Australia markets open in 7 hours 26 minutes

Zymergen Inc. (ZY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.3320+0.0620 (+4.88%)
As of 12:34PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close1.2700
Open1.2700
Bid1.3300 x 1000
Ask1.3400 x 2200
Day's range1.2700 - 1.3400
52-week range1.2600 - 46.0500
Volume522,794
Avg. volume1,152,088
Market cap137.384M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-3.6100
Earnings date12 May 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.88
  • Motley Fool

    Zymergen Inc. (ZY) Q1 2022 Earnings Call Transcript

    If you require any further assistance, I would now like to hand the conference over to your host today, Carrie Mendivil from investor relations. Earlier today, Zymergen released preliminary substantial results for the quarter ended March 31, 2022. Joining me today from Zymergen are Jay Flatley, acting chief executive officer, and Ena Singh, chief financial officer.

  • Zacks

    Zymergen (ZY) Reports Q1 Loss, Tops Revenue Estimates

    Zymergen (ZY) delivered earnings and revenue surprises of 1.41% and 57.08%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Zymergen Reports Preliminary First Quarter 2022 Financial Results

    EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial results for the first quarter ended March 31, 2022. “Our mission at Zymergen is to partner with nature to make better products, a better way, for a better world. One of the key transformations we have made is to create a nimble, disciplined product development process,” said Zymergen’s interim CEO, Jay Flatley. “We now have the infrastructur